The prospect of creating artery “banks” could transform treatment of many common heart and vascular ailments. But it’s a big leap from concept to reality.
health & medicine
Madison startup advances three-in-one cancer drug rooted at UW
The first target for Co-D is angiosarcoma, a rare and lethal cancer that arises from blood vessels.
Stem cell ‘heart patch’ moves closer to clinic
The promise of stem cells to treat cardiovascular disease may soon be a step closer to overcoming the last big hurdle before trials in human patients.
UW-Madison spinoff gets FDA OK for bacteria-killing wound dressing
Microlyte, patented by Imbed Biosciences, will compete in the $2 billion market sector of “advanced wound dressings,” which are used to treat ulcers, burns, bedsores and other difficult wounds.
Botulinum toxin may travel further than expected in nerve cells
Two specific toxins — including the popular drug Botox — have multiple uses for treating many neuromuscular conditions, including frown lines, disabling muscle spasms and migraine headaches.
Benign bacteria block mosquitoes from transmitting Zika, chikungunya viruses
The bacteria could present a “novel biological control mechanism,” aiding efforts to stop the spread of Zika virus.
Monkey study shows Zika infection prolonged in pregnancy
Researchers have shown that one infection with Zika virus protects against future infection, though pregnancy may drastically increase the time the virus stays in the body.
Novel mouse model sheds new light on autism spectrum disorder
These sorts of studies cannot be performed in humans, hence the need to develop and study mouse models.
New strategy could yield more precise seasonal flu vaccine
The new approach would better forecast the naturally occurring mutations that help seasonal flu virus dodge vaccines.
Gene regulatory mutation linked to rare childhood cancer
This basic knowledge of a specific cancer is essential to start drug testing, says researcher Peter Lewis.